Expandable tip assembly for thrombus management
Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
1. An expandable tip assembly adapted to address an occlusive thrombus within a blood vessel, comprising:
an elongate member;
a tubular scaffold coupled to a distal end of the elongate member, the scaffold comprising a plurality of cells and configured to radially self-expand from a non-expanded configuration within a catheter to an expanded configuration upon unsheathing of the scaffold from the catheter;
wherein the scaffold has, across scaffold diameters of 2.0 mm to 4.5 mm, a radial resistive force (RRF) range per unit length of 0.005 N/mm to 0.016 N/mm.
2. The expandable tip assembly of claim 1 , wherein the scaffold has a RRF of 0.011 N/mm to 0.016 N/mm at a scaffold diameter of 2.0 mm, and of 0.005 N/mm to 0.007 N/mm at a scaffold diameter of 4.5 mm.
3. The expandable tip assembly of claim 1 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of between 0.0067 N/mm and 0.0138 N/mm.
4. The expandable tip assembly of claim 3 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of between 0.0070 N/mm and 0.0130 N/mm.
5. The expandable tip assembly of claim 4 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of 0.0083 N/mm to 0.0127 N/mm.
6. The expandable tip assembly of claim 1 , wherein the scaffold comprises an open distal end without a distal embolic protection member or device.
7. The expandable tip assembly of claim 6 , wherein a proximal end of the scaffold is open.
8. The expandable tip assembly of claim 1 , wherein the scaffold is coupled to the distal end of the elongate member by a plurality of tethers that extend eccentrically from the distal end of the elongate member.
9. The expandable tip assembly of claim 1 , wherein the cells of the scaffold have a variable cell size.
10. The expandable tip assembly of claim 1 , wherein the cells of the scaffold have a uniform cell size.
11. The expandable tip assembly of claim 1 , wherein the cells of the scaffold have a cell length of between 4 mm and 6 mm and a cell height between 2 mm and 4 mm in the expanded configuration.
12. The expandable tip assembly of claim 1 , wherein a proximal end of the scaffold is tapered to facilitate re-sheathing of the scaffold.
13. The expandable tip assembly of claim 1 , wherein the scaffold is permanently, non-removably coupled to the elongate member.
14. The expandable tip assembly of claim 1 , wherein the scaffold is detachably coupled to the elongate member.
15. The expandable tip assembly of claim 1 , wherein the scaffold has a length from about 5 mm to about 50 mm.
16. The expandable tip assembly of claim 1 , wherein the scaffold comprises one or more of the following features:
a tapered body;
a coating configured to increase platelet activation or adhesion of the thrombus to the scaffold;
a length configured to at least partially span the thrombus;
sufficient radial force to provide continuous radial expansion as the thrombus is lysed; and
is not a rolled mesh scaffold that is configured to overlap on itself.
17. The expandable tip assembly of claim 1 , wherein the scaffold comprises one or more of the following features:
a body having a triangular, elliptical, spiral or undulating configuration;
a non-thrombogenic coating or a coating with an anti-clotting drug;
a ratio of strut thickness to strut width is less than 1.4;
parallelogram-shaped cells; and
U-shaped bridges between cells of the scaffold.
18. The expandable tip assembly of claim 1 , wherein the scaffold comprises a laser-cut tube.
19. The expandable tip assembly of claim 1 , wherein the plurality of cells is defined by struts and bridges.
20. An expandable tip assembly adapted to address an occlusive thrombus within a blood vessel, comprising:
an elongate member;
a tubular scaffold coupled to a distal end of the elongate member, the scaffold comprising a plurality of cells and configured to radially self-expand from a non-expanded configuration within a catheter to an expanded configuration upon unsheathing of the scaffold from the catheter;
wherein the scaffold has a radial resistive force (RRF) of 0.011 N/mm to 0.016 N/mm at a scaffold diameter of 2.0 mm, and of 0.005 N/mm to 0.007 N/mm at a scaffold diameter of 4.5 mm.
21. The expandable tip assembly of claim 20 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of between 0.0067 N/mm and 0.0138 N/mm.
22. The expandable tip assembly of claim 21 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of between 0.0070 N/mm and 0.0130 N/mm.
23. The expandable tip assembly of claim 22 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of 0.0083 N/mm to 0.0127 N/mm.
24. An expandable tip assembly adapted to address an occlusive thrombus within a blood vessel, comprising:
an elongate member;
a tubular scaffold coupled to a distal end of the elongate member, the scaffold comprising a plurality of cells and configured to radially self-expand from a non-expanded configuration within a catheter to an expanded configuration upon unsheathing of the scaffold from the catheter;
wherein the scaffold has, across scaffold diameters of 2.0 mm to 4.5 mm, an average radial resistive force (RRF) per unit length of between 0.0067 N/mm and 0.0138 N/mm.
25. The expandable tip assembly of claim 24 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of between 0.0070 N/mm and 0.0130 N/mm.
26. The expandable tip assembly of claim 25 , wherein the scaffold has, across scaffold diameters of 2 mm to 4.5 mm, an average RRF per unit length of 0.0083 N/mm to 0.0127 N/mm.